1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Velaglucerase alfa
Trade Name:
Vpriv
Manufacturer/Distributor:
Shire Human Genetic Therapies Inc., distributed by Paladin Labs
Classification:
Enzyme replacement for treatment of Gaucher disease
ATC Class:
A16AB10 - velaglucerase alfa
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/10/01
Date Marketed in Canada (yyyy/mm/dd):
2010/11/22
Presentation:
Powder for solution: 400 units/vial; DIN: 02357119
Comments:
Enzyme replacement therapy for adult and pediatric patients with type 1 Gaucher disease. It is a glycoprotein with the same amino acid sequence as the naturally occurring human enzyme, glucocerebrosidase.
Back to:
Drug Product Listings 
